There is virtually no topic that has been more in the medical and general health consumer news recently than the discussion of the microbiome and the diversity of impacts it has on human health. The effects have ranged from obesity to diabetes to dementia, heart disease, arthritis, and cancer. It is presently the topic of greatest clinical focus due to the fact that the composition of the microbiome is modifiable through diet, lifestyle, and environmental exposures.

The impact of the microbiome on an individual’s metabolism has been demonstrated to occur through the interaction of the specific species of organisms that make up the microbiome with the individual’s nervous and immune systems. Each individual has been found to have a unique microbiome and therefore individualized relationship among their microbiome and their nervous and immune systems. The understanding of this unique relationship between the microbiome and the individual’s immune system coupled with the recognition that the individual’s diet, lifestyle, and environment can influence the function of their immune system results in the increasing importance of personalized lifestyle medicine.

This program will focus on providing a new understanding of the concepts of dysbiosis, endotoxicity, leaky gut and immune dysfunction related to the interaction of the intestinal microbiome with the gastrointestinal-associated immune system. Both advances in assessing the impact of the intestinal microbiome on immune function, and the delivery of personalized care will be provided by faculty members Dr. Michael Chapman and Dr. Alenda Pribyl. This conference will provides important “news to use” in managing clinical issues that emerge from the interaction of the intestinal microbiome with the gastrointestinal immune and enteric nervous systems.

Dr. Jeffrey Bland, PhD
Michael Chapman, ND
Alena Pribyl, Ph.D.